Facilitated By

San Antonio Medical Foundation

News

  • Bb Biotech Ag Has Trimmed Its Regeneron Pharmaceuticals (REGN) Position; Oberweis Asset ...

    Bb Biotech Ag decreased Regeneron Pharmaceuticals Inc. (REGN) stake by ... Bb Biotech Ag sold 10,000 shares as Regeneron Pharmaceuticals Inc. .... Energy for project at Joint Base San Antonio – Seeking Alpha” published on ...

  • Moderna is sliding in its Wall Street debut after the biggest IPO in biotech history (MRNA, TBIO)

    Moderna Therapeutics just started trading, after the biggest initial public offering in biotech history. The stock slid 5.7 percent to $21.65 in its trading ...

  • Myriad study shows breast cancer recurrence test can predict therapy responses

    The studies were presented at the San Antonio Breast Cancer Symposium. A retrospective analysis of five prospective studies evaluated 3,746 ...

  • Leaders in SA biotech, military medicine to meet in inaugural summit

    Several of San Antonio's heavy hitters in bioscience plan to meet with their military counterparts in the Alamo City in an effort to develop deeper ...

  • Puma Biotechnology Presents Results from the Hormone Receptor Positive Subgroup in Phase III ...

    ... Subgroup in Phase III ExteNET Trial of Neratinib for HER2-Amplified, Early Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium.